In this study, RLM-RACE was used to identify the transcriptional start site 387 bp upstream of the translational start. Evolutionarily conserved transcription factor binding sites were identified, and a series of luciferase reporter constructs driven by BMPR2 promoter elements used to determine their functional relevance. We found the promoter area from 983 bp to 90 bp upstream of the transcriptional start gave maximal activity, greater than longer constructs, with an area between 570 bp and 290 bp upstream of the transcriptional start containing an important repressor element. To characterize this repressor, we used a combination of EMSA, mutation of the EGR1 binding site, transfection with EGR1 and NAB1 constructs, and mutation of the NAB1 binding site within the EGR1 protein. From this we conclude that EGR1 is essential to BMPR2 transcription, but that NAB1 binding to EGR1 causes it to act as a repressor.
Bellusci, S., et al. (1996) Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis. Development, 122, 1693-1702.
Hild, M., et al. (2000) The roles of BMPs, BMP antagonists, and the BMP signaling transducers Smad1 and Smad5 during dorsoventral patterning of the zebrafish embryo. Ernst Schering Research Foundation Workshop, 29, 81-106.
Iwasaki, S., et al. (1995) Distribution and characterization of specific cellular binding proteins for bone mor-phogenetic protein-2. Journal of Biological Chemistry, 270, 5476-82.
Nohe, A., et al. (2002) The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. Journal of Biological Chemistry, 277, 5330-5338.
Kawabata, M., Chytil, A. and Moses, H.L. (1995) Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-beta receptor. Journal of Biological Chemistry, 270, 5625-5630. doi:10.1074/jbc.270.10.5625
Nohno, T., et al. (1995) Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. Journal of Biological Chemistry, 270, 22522-22526.
Cogan, J.D., et al. (2006) High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine, 174, 590-598.
Deng, Z., et al. (2000) Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. American Journal of Human Genetics, 67, 737-744.
Lane, K.B., et al. (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nature Genetics, 26, 81-84. doi:10.1038/79226
Thomson, J.R., et al. (2000) Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. Journal of Medicine Genetics, 37, 741-745. doi:10.1136/jmg.37.10.741
Humphries, D.E., et al. (1994) Structure and expression of the promoter for the human type II transforming growth factor-beta receptor. Biochemical and Biophysical Research Communications, 203, 1020-1027.
Ahn, B.H., et al. (2007) Phorbol myristate acetate-induced EGR-1 expression is suppressed by phospholipase D isozymes in human glioma cells. FEBS Letters, 581, 5940-5944. doi:10.1016/j.febslet.2007.11.077
Dunnmon, P.M., et al. (1990) Phorbol esters induce immediate-early genes and activate cardiac gene transcription in neonatal rat myocardial cells. Journal of Molecular and Cellular Cardiology, 22, 901-910.
Maass, A., et al. (1994) Mitogenic signals control translation of the early growth response gene-1 in myogenic cells. Biochemical and Biophysical Research Communications, 202, 1337-1346. doi:10.1006/bbrc.1994.2077
You, L. and Jakowlew, S.B. (1997) Identification of early growth response gene-1 (EGR-1) as a phorbol myristate acetate-induced gene in lung cancer cells by differential mRNA display. American Journal of Respiratory and Critical Care Medicine, 17, 617-624.
Sevetson, B.R., Svaren, J. and Milbrandt, J. (2000) A novel activation function for NAB proteins in EGR-dependent transcription of the luteinizing hormone beta gene. Journal of Biological Chemistry, 275, 9749-9757. doi:10.1074/jbc.275.13.9749
Tourtellotte, W.G., et al. (2000) Functional compensation by EGR4 in EGR1-dependent luteinizing hormone regulation and Leydig cell steroidogenesis. Molecular and Cellular Biology, 20, 5261-5268.
Russo, M.W., Sevetson, B.R. and Milbrandt, J. (1995) Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proceedings of the National Academy of Sciences, USA, 92, 6873-6877.
Wang, C., et al. (2005) EGR-1 negatively regulates expression of the sodium-calcium exchanger-1 in cardiomyocytes in vitro and in vivo. Cardiovascular Research, 65, 187-194. doi:10.1016/j.cardiores.2004.09.026
Aldred, M.A., et al. (2007) Characterization of the BMPR2 5'-untranslated region and a novel mutation in pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine, 176, 819-824.
Wang, H., et al. (2009) Novel promoter and exon mutations of the BMPR2 gene in Chinese patients with pulmonary arterial hypertension. European Journal of Human Genetics, 17, 1063-1069. doi:10.1038/ejhg.2009.3
Lee, Y.S., et al. (2005) Adenoviral-mediated delivery of early growth response factor-1 gene increases tissue perfusion in a murine model of hindlimb ischemia. Molecular Therapy, 12, 328-336.
Szabo, I.L., et al. (2001) NSAIDs inhibit the activation of Egr-1 gene in microvascular endothelial cells: A key to inhibition of angiogenesis? Journal of Physiology, Paris, 95, 379-383. doi:10.1016/S0928-4257(01)00051-1
Rondelet, B., et al. (2005) Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension. American Journal of Physiology-Heart and Circulatory Physiology, 289, 2319-2324.
Quinones, A., Dobberstein, K.U. and Rainov, N.G. (2003) The EGR-1 gene is induced by DNA-damaging agents and non-genotoxic drugs in both normal and neoplastic human cells. Life Science, 72, 2975-2992.
Stula, M., et al. (2000) Influence of sustained mechanical stress on EGR-1 mRNA expression in cultured human endothelial cells. Molecular and Cellular Biochemistry, 210, 101-108. doi:10.1023/A:1007126218740